20160128 EGA Regulatory and Scientific Affairs Conferenc

Industry Welcomes the European Commission Workshop on the Uptake of Biosimilar Medicines

20 June 2016

The European pharmaceutical industry welcomes the workshop organised today by […]

Read more

European Health Ministers Call for More Competition in Pharmaceutical Markets

17 June 2016

Medicines for Europe will engage rapidly with Health Ministers across […]

Read more

IGBA Joins ICH and Welcomes the Positive Vote of the General Assembly

15 June 2016

Read More

Biosimilar Medicines for Rheumatologists: Bridging the Gap between Regulatory Science and Medical Societies

10 June 2016

Over the past decade, biosimilar medicines have generated more than […]

Read more

Generic, Biosimilar and Value Added Medicines Industry Leaders Join Forces to Drive Access to Medicines Agenda

9 June 2016

During the next two days, the key pharmaceutical industry leaders […]

Read more

Biosimilar Medicines for Rheumatologists: Understanding the Science of Extrapolation / 10th June 2016, 08:15–09:45 Capital Suite 09, ExCel London

17 May 2016

Read More

10 Years of Biosimilar Medicines: Transforming Healthcare

28 April 2016

Biosimilar medicines provide an opportunity to increase patient access to […]

Read more

6 out of 10 Doctors Have Already Prescribed Biosimilar Medicines, According to EuropaBio Paper

20 April 2016

Medicines for Europe and its Biosimilar Medicines Group took note […]

Read more

Medicines for Europe Reinforces its Commitment to Promote Universal Access to Health

19 April 2016

Over 100 participants will explore different ways and opportunities to […]

Read more

100% increase in Patient Access to Biologic Treatments thanks to Biosimilar Medicines

30 March 2016

Biosimilar medicines represent an essential opportunity to optimise patient access to […]

Read more

Subscribe to our newsletter

[contact-form-7 id="1638" title="Newsletter subscription"]